Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,461 public trials 1,143 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer

NCT04837209

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

NCT04298086

Conditions
Body Weight, Breast Cancer, Breast Diseases, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

PALbociclib CoLlaborative Adjuvant Study

NCT02513394

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Southern Cancer Center PC - Providence Mobile, Alabama, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Cancer Center Anchorage, Alaska, United States
View all 437 locations
View Trial Details
Active, Not Recruiting

A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

NCT05629585

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
View all 276 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

NCT04191499

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

NCT04421963

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +18 more
Locations
  • Research Site Boca Raton, Florida, United States
  • Research Site Towson, Maryland, United States
  • Research Site Detroit, Michigan, United States
  • Research Site Minneapolis, Minnesota, United States
View all 107 locations
View Trial Details

Related conditions